Effect of lysolecithin treatment on the structure and functions of the mitochondrial inner membrane.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003580:Cytochromes / Q000032:analysis; D003720:Densitometry; D004579:Electron Transport; D006321:Heart / Q000187:drug effects; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008566:Membranes / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D008854:Microscopy, Electron; D008931:Mitochondria, Muscle / Q000032:analysis / Q000187:drug effects* / Q000378:metabolism; D009206:Myocardium / Q000032:analysis / Q000166:cytology / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D011188:Potassium / Q000494:pharmacology; D014634:Valinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D003580:Cytochromes; D008244:Lysophosphatidylcholines; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D014634:Valinomycin; D000255:Adenosine Triphosphate; D011188:Potassium